PKD / PKCmu (fosfo Ser910) Antilichaam

Converts transient diacylglycerol. (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress through activation of NF-κ -B.

5587

Q15139

NP_002733.2

Human, Mouse, Rat

PKD/PKCmu (Phospho-Ser910) antibody was raised against a peptide sequence around phosphorylation site of serine 910 (R-V-S (p) -I-L) derived from Human PKD/PKCμ .

Unconjugated

Primary Antibodies

Phospho-Specific, Apoptosis, Cancer, Neuroscience

Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Phospho-Specific

Blue Ice

Store antibody at -20˚ C for up to one year.

115 kDa

This antibody detects endogenous level of PKD/PKCmu only when phosphorylated at serine 910.

Western Blot: 1:500~1:1000, Immunofluorescence: 1:100~1:200

PRKD1

Protein kinase D1

Homo sapiens

Matthews SA, et al. J Biol Chem 1999 Sep; 274 (37) : 26543-26549Brandlin I, et al. J Biol Chem 2002 Feb; 277 (8) : 6490-6496Storz P, et al. Mol Pharmacol 2004 Oct; 66 (4) : 870-879

PKD, PKCM, PRKCM, PKC-MU, BBC6, BCL2L8, KPCD1, PKC-mu, PKD

WB, IF

115529463

Liquid